Hansa Biopharma (Sweden) Analysis
| HNSA Stock | SEK 30.68 0.80 2.68% |
Hansa Biopharma AB is fairly valued with Real Value of 30.06 and Hype Value of 30.68. The main objective of Hansa Biopharma stock analysis is to determine its intrinsic value, which is an estimate of what Hansa Biopharma AB is worth, separate from its market price. There are two main types of Hansa Biopharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Hansa Biopharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Hansa Biopharma's stock to identify patterns and trends that may indicate its future price movements.
The Hansa Biopharma stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Hansa Biopharma is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Hansa Stock trading window is adjusted to Europe/Stockholm timezone.
Hansa |
Hansa Stock Analysis Notes
About 41.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 13.1. Hansa Biopharma AB had not issued any dividends in recent years. The entity had 1015:964 split on the 16th of March 2015. Hansa Biopharma AB , a biopharmaceutical company, focuses on developing novel immunomodulatory enzymes for organ transplantation and autoimmune diseases. Hansa Biopharma AB was founded in 2001 and is headquartered in Lund, Sweden. Hansa Biopharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 60 people. To learn more about Hansa Biopharma AB call Sren MSc at 46 46 16 56 70 or check out https://www.hansabiopharma.com.Hansa Biopharma AB Investment Alerts
| Hansa Biopharma AB generated a negative expected return over the last 90 days | |
| Hansa Biopharma AB has high historical volatility and very poor performance | |
| Hansa Biopharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 154.53 M. Net Loss for the year was (609.57 M) with profit before overhead, payroll, taxes, and interest of 116.05 M. | |
| Hansa Biopharma AB has accumulated about 762.73 M in cash with (504.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.06. |
Hansa Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hansa Biopharma's market, we take the total number of its shares issued and multiply it by Hansa Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 23rd of November, Hansa Biopharma retains the Market Risk Adjusted Performance of 8.19, standard deviation of 3.55, and Risk Adjusted Performance of (0.16). Hansa Biopharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Hansa Biopharma AB Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Hansa Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Hansa Biopharma AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Hansa Biopharma Outstanding Bonds
Hansa Biopharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hansa Biopharma AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hansa bonds can be classified according to their maturity, which is the date when Hansa Biopharma AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Hansa Biopharma Predictive Daily Indicators
Hansa Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hansa Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Hansa Biopharma Forecast Models
Hansa Biopharma's time-series forecasting models are one of many Hansa Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hansa Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Hansa Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Hansa Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hansa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hansa Biopharma. By using and applying Hansa Stock analysis, traders can create a robust methodology for identifying Hansa entry and exit points for their positions.
Hansa Biopharma AB , a biopharmaceutical company, focuses on developing novel immunomodulatory enzymes for organ transplantation and autoimmune diseases. Hansa Biopharma AB was founded in 2001 and is headquartered in Lund, Sweden. Hansa Biopharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 60 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Hansa Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Additional Tools for Hansa Stock Analysis
When running Hansa Biopharma's price analysis, check to measure Hansa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hansa Biopharma is operating at the current time. Most of Hansa Biopharma's value examination focuses on studying past and present price action to predict the probability of Hansa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hansa Biopharma's price. Additionally, you may evaluate how the addition of Hansa Biopharma to your portfolios can decrease your overall portfolio volatility.